Priority Date: 19.05.08 (US 20080054310P)

Heterocyclic compounds as factor IXA inhibitors.

  • Application ID: EP14173412
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
4 offices
Technology Company
no operation time available
7 offices
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Merck & Co. Inc. and Merck Sharp & Dohme Ltd. are specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 224 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 19.05.2008 - Priority Date (US 20080054310P)
  • 26.11.2014 - Publication A1 (EP2805939)